Credit Agricole Downgrades Bio-Rad Labs (BIO) to Outperform
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $296.11 -0.39%
Rating Summary:
9 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 17
Rating Summary:
9 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 17
Join SI Premium – FREE
Credit Agricole downgraded Bio-Rad Labs (NYSE: BIO) from Buy to Outperform, price target lowered from $133 to $110.
For an analyst ratings summary and ratings history on Bio-Rad Labs click here. For more ratings news on Bio-Rad Labs click here.
Shares of Bio-Rad Labs closed at $91.94 yesterday.
For an analyst ratings summary and ratings history on Bio-Rad Labs click here. For more ratings news on Bio-Rad Labs click here.
Shares of Bio-Rad Labs closed at $91.94 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Downgrades Cosmos Pharmaceuticals Corp. (3349:JP) (CSMYF) to Equalweight
- Macquarie Double Upgrades Kinsus Interconnect Technology Corp (3189:TT) to Outperform
- Morgan Stanley Downgrades China Yongda Automotive Services Holdings Ltd (3669:HK) (CYYHF) to Underweight
Create E-mail Alert Related Categories
DowngradesRelated Entities
Credit AgricoleSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
